MDXL

MediXall Group, Inc. [MDXL] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

MDXL Stock Summary

In the News

08:00 28 Mar 2024 MDXL

MediXall Group & Health Karma(R) CEO to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Wednesday, January 25th

FORT LAUDERDALE, FL / ACCESSWIRE / January 24, 2023 / MediXall Group Inc. (OTCQB:MDXL) ("MediXall"), an innovative healthcare solutions provider, is pleased to announce that MediXall and Health Karma Chief Executive Officer, Travis Jackson has been invited to present at the Healthcare IT Virtual Conference, presented by Maxim Group LLC and hosted by M-Vest, on Wednesday, January 25th, 2023 at 2:45 pm ET. Mr. Jackson will be presenting on a panel focused on "Improving Patient Outcomes & Experiences".

12:10 28 Mar 2024 MDXL

Innovative Healthcare Solutions Provider 'Health Karma' Reports Many Accomplishments To Date This Year

FT. LAUDERDALE, FL / ACCESSWIRE / August 25, 2021 / MediXall Group, Inc. (OTCQB:MDXL), a leading innovative healthcare solutions provider, today provided an update on the growth and accomplishments of its wholly owned subsidiary, Health Karma™ this year. To date, 2021 has been very positive for Health Karma, with the company accomplishing the following: Appointed Experienced Health Insurance Technology Executive Travis Jackson as New Chief Executive Officer of Health Karma.

09:00 28 Mar 2024 MDXL

MediXall Group Announces Appointment of Experienced Health Insurance Technology Executive Travis Jackson as New Chief Executive Officer of Health Karma

FORT LAUDERDALE, FL / ACCESSWIRE / August 17, 2021 / MediXall Group, Inc. (OTCQB:MDXL), an innovative healthcare solutions provider, announced today that healthcare technology executive Travis Jackson has been appointed Chief Executive Officer (CEO)of its wholly-owned subsidiary, Health Karma. Mr. Jackson appointment went effective, August 16th.

09:00 28 Mar 2024 MDXL

MediXall Group Hires Leading PR Firm, TransMedia Group, to Drive Brand Awareness & Media Relations to Propel Health Karma on Its Next Phase of Growth

FORT LAUDERDALE, FL / ACCESSWIRE / August 5, 2021 / MediXall Group, Inc. (OTCQB:MDXL), an innovative healthcare solutions provider, announced that the leading international public relations firm, Transmedia Group, will generate media coverage highlighting the positive impact its wholly owned subsidiary, Health Karma, has had on health and wellness of individuals and employees of businesses nationwide. The PR campaign will focus on Health Karma's success as it enters the next phase of growth and seeks to expand its footprint on healthcare.

08:30 28 Mar 2024 MDXL

MediXall Group Subsidiary Health Karma Mental Health Awareness Campaign Drives Consumer Acquisition

FORT LAUDERDALE, FL / ACCESSWIRE / May 18, 2021 / MediXall Group, Inc. (OTCQB:MDXL) is pleased to report that its wholly owned subsidiary, Health Karma, is experiencing business growth and momentum as it drives new consumer acquisition through its Mental Health Awareness Campaign. Stated Jonathan Martinez, Lead Growth Marketer at Health Karma, "We've seen phenomenal performance with our mental health performance marketing campaigns - the CTR on these campaigns are +38.46% the baseline.

08:30 28 Mar 2024 MDXL

As Big Pharma Continues to Hike Prices, Health Karma, Subsidiary of MediXall Group, Reduces Cost of Prescription Medications

PRESIDENT BIDEN'S AMERICAN FAMILIES PLAN UNVEILED LAST WEDNESDAY DOES NOT INCLUDE PROPOSAL TO CUT PRESRIPTION DRUG PRICES FORT LAUDERDALE, FL / ACCESSWIRE / May 5, 2021 / MediXall Group, Inc. (OTCQB:MDXL) reported today that its subsidiary, Health Karma, is reducing the cost of prescription medications by delivering RX discounts to consumers through the Health Karma online platform. This comes at a critical time as Big Pharma continues to increase medication prices even as individuals are struggling through a pandemic and economic crisis.

08:30 28 Mar 2024 MDXL

MediXall Group Launching New Campaign Through Health Karma in Support of Mental Health Awareness Month

AS COVID-19 STRETCHES INTO A SECOND YEAR, MEDIXALL GROUP PROVIDES ESSENTIAL MENTAL HEALTH SUPPORT FORT LAUDERDALE, FL / ACCESSWIRE / April 29, 2021 / In support of Mental Health Awareness Month, MediXall Group, Inc. (OTCQB:MDXL), reported today that its wholly-owned subsidiary, Health Karma, developed a new campaign in support of mental health awareness month. During the month of May, new users who sign up for Health Karma will receive one free month of Health Karma's total health plan which includes access to a network of licensed therapists to address mental health concerns.

08:30 28 Mar 2024 MDXL

Partner Program Fuels Medixall Group Subsidiary Sales

Wise Health Plans Signs as Partner To Deliver Affordable Healthcare for All FORT LAUDERDALE, FL / ACCESSWIRE / April 27, 2021 / MediXall Group, Inc. (OTCQB:MDXL), an innovative healthcare solutions provider, announced today that its subsidiary, Health Karma, is signing up agencies and brokerage firms as part of its new Health Karma Partner Program geared toward building a multi-tiered sales channel to accelerate market adoption. WISE Health Plans, an insurance brokerage firm located in Utah, has completed the onboarding process, and is preparing to launch a Health Karma marketing campaign to support its mission to deliver affordable healthcare for all.

08:30 28 Mar 2024 MDXL

Technology Giants Flock to Healthcare Arena; MediXall Group Targets Additional Acquisitions

FORT LAUDERDALE, FL / ACCESSWIRE / April 20, 2021 / MediXall Group, Inc. (OTCQB:MDXL), an innovative healthcare solutions provider, announced today that it has targeted key acquisition candidates as it plans to roll out an aggressive acquisition strategy over the next three months. The announcement comes at a time when technology giants are flocking to the healthcare arena as the pandemic has showcased the value of technology in healthcare.

10:15 28 Mar 2024 MDXL

MediXall Group Reports Skyrocketed Conversion Rates for Health Karma Social Media Campaigns

Conversion rates more than double industry standards. FORT LAUDERDALE, FL / ACCESSWIRE / April 14, 2021 / MediXall Group, Inc. (OTCQB:MDXL), an innovative healthcare solutions provider, was pleased to announce today that the Health Karma direct-to-consumer social media campaigns are consistently reporting over 20% conversion rates.

MDXL Financial details

Company Rating
Sell
Market Cap
130
Income
-6.83M
Revenue
59.27K
Book val./share
-0.03
Cash/share
0
Dividend
-
Dividend %
-
Employees
17
Optionable
No
Shortable
Yes
Earnings
09 Aug 2023
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-0.77
LT Debt / Equity
-0.05
-
-
EPS (TTM)
-0.06
EPS next Y
-
EPS next Q
-
EPS this Y
1.04%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
4.97%
Revenue last 5Y
99.87%
Revenue Q/Q
-2.52%
EPS Q/Q
61.29%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
-0%
ROA
-333%
ROE
87%
ROC
0.75%
Gross Margin
100%
Oper. Margin
-6323%
Profit Margin
-6995%
Payout
-
Shs Outstand
130.49M
Shs Float
123.42M
-
-
-
-
Target Price
-
52W Range
1.0E-6-1.11
52W High
-
52W Low
-
RSI
31.82
Rel Volume
-
Avg Volume
-
Volume
Perf Week
0%
Perf Month
-
Perf Quarter
-
Perf Half Y
-80%
-
-
-
-
Beta
-0.56
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.0004
Change
0%

MDXL Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
-0.05-0.05-0.07-0.06-0.06
Operating cash flow per share
-0.03-0.03-0.04-0.04-0.03
Free cash flow per share
-0.04-0.03-0.04-0.05-0.03
Cash per share
00.010.0100
Book value per share
0.010.0100-0.03
Tangible book value per share
000-0.01-0.04
Share holders equity per share
0.010.0100-0.03
Interest debt per share
00000.03
Market cap
146.28M148.27M83.38M109.41M74.66M
Enterprise value
146.08M147.94M82.95M109.67M77.48M
P/E ratio
-49.03-43.34-14.06-18.13-10.93
Price to sales ratio
78.73K55.22K07.3K1.26K
POCF ratio
-65.74-63.31-23.8-23.35-20.97
PFCF ratio
-58.35-62.88-23.19-23.29-20.96
P/B Ratio
269.41372.76218.33-321.69-20.35
PTB ratio
269.41372.76218.33-321.69-20.35
EV to sales
78.62K55.1K07.31K1.31K
Enterprise value over EBITDA
-49.01-44.15-13.99-16.8-12.33
EV to operating cash flow
-65.65-63.17-23.68-23.41-21.76
EV to free cash flow
-58.27-62.75-23.07-23.34-21.75
Earnings yield
-0.02-0.02-0.07-0.06-0.09
Free cash flow yield
-0.02-0.02-0.04-0.04-0.05
Debt to equity
00.30.56-0.93-0.77
Debt to assets
00.130.130.283.27
Net debt to EBITDA
0.070.10.07-0.04-0.45
Current ratio
1.950.91.010.280
Interest coverage
0000-25.19
Income quality
0.750.680.590.760.52
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
1.56K1.28K0426.6698.55
Research and developement to revenue
00000.66
Intangibles to total assets
0.480.380.270.40.66
Capex to operating cash flow
0.130.010.0300
Capex to revenue
-151.53-5.860-0.86-0.02
Capex to depreciation
-89.52-0.23-22.89-3.21-0.04
Stock based compensation to revenue
537.01239.57090.8833.15
Graham number
0.090.070.080.070.2
ROIC
-5.18-5.4-9.24-21.8412.18
Return on tangible assets
-7.91-5.89-4.93-8.87-23.28
Graham Net
00-0.01-0.01-0.04
Working capital
176.34K-47.72K12.55K-882.39K-4.33M
Tangible asset value
191.5K41.06K-57.5K-791.53K-4.24M
Net current asset value
176.34K-94K-127.79K-1.13M-4.52M
Invested capital
00.30.56-0.93-0.77
Average receivables
80.3K80.3K000
Average payables
389.02K304.17K496.99K580.14K844.51K
Average inventory
00000
Days sales outstanding
31.55K0000
Days payables outstanding
39.62112.2882.4370.09125.56
Days of inventory on hand
00000
Receivables turnover
0.010000
Payables turnover
9.213.254.435.212.91
Inventory turnover
00000
ROE
-5.49-8.6-15.5317.741.86
Capex per share
00000

Quarterly Fundamentals Overview

Last date of statement is 2022-12-31 for Q4

Metric History 2021-12-312022-03-312022-06-302022-09-30 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
-0.02-0.02-0.01-0.01-0.01
Operating cash flow per share
-0.01-0.01-0.01-0.01-0.01
Free cash flow per share
-0.01-0.01-0.01-0.01-0.01
Cash per share
00000
Book value per share
0-0.01-0.02-0.03-0.03
Tangible book value per share
-0.01-0.01-0.02-0.03-0.04
Share holders equity per share
0-0.01-0.02-0.03-0.03
Interest debt per share
00.010.010.020.02
Market cap
111.25M229.25M46.47M19.77M76.14M
Enterprise value
111.5M229.87M47.92M21.97M78.96M
P/E ratio
-15.3-23.78-7.48-4.55-10.68
Price to sales ratio
-701.0328.99K4.49K951.983.76K
POCF ratio
-111.81-203.27-49.59-22.02-127.26
PFCF ratio
-111.72-202.96-49.59-22.02-126.97
P/B Ratio
-327.08-339.38-26.34-6.78-20.75
PTB ratio
-327.08-339.38-26.34-6.78-20.75
EV to sales
-702.6129.07K4.63K1.06K3.9K
Enterprise value over EBITDA
-61.34-95.49-30.86-20.27-53.45
EV to operating cash flow
-112.06-203.82-51.14-24.47-131.97
EV to free cash flow
-111.97-203.51-51.14-24.47-131.67
Earnings yield
-0.02-0.01-0.03-0.05-0.02
Free cash flow yield
-0.010-0.02-0.05-0.01
Debt to equity
-0.93-1.07-0.92-0.78-0.77
Debt to assets
0.280.591.42.243.27
Net debt to EBITDA
-0.14-0.26-0.93-2.04-1.91
Current ratio
0.280.180.140.030
Interest coverage
000-525.410
Income quality
0.550.470.60.830.34
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
-11.6305.81151.1253.1972.8
Research and developement to revenue
00001.92
Intangibles to total assets
0.40.560.580.630.66
Capex to operating cash flow
00000
Capex to revenue
0.01-0.2100-0.07
Capex to depreciation
-5.25-0.6300-0.04
Stock based compensation to revenue
-4.25138.480-11.6936.91
Graham number
0.040.050.070.070.1
ROIC
15.05-6.91-11.182.932.59
Return on tangible assets
-2.67-4.43-3.17-2.87-6.07
Graham Net
-0.01-0.02-0.02-0.03-0.04
Working capital
-882.39K-1.01M-1.15M-3.6M-4.33M
Tangible asset value
-791.53K-1.36M-2.43M-3.56M-4.24M
Net current asset value
-1.13M-1.67M-2.73M-3.84M-4.52M
Invested capital
-0.93-1.07-0.92-0.78-0.77
Average receivables
00000
Average payables
518.83K0651.96K1.08M973.33K
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
000278.95162
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
0000.320.56
Inventory turnover
00000
ROE
5.343.570.880.370.49
Capex per share
00000

MDXL Frequently Asked Questions

What is MediXall Group, Inc. stock symbol ?

MediXall Group, Inc. is a US stock , located in Fort lauderdale of Fl and trading under the symbol MDXL

What is MediXall Group, Inc. stock quote today ?

MediXall Group, Inc. stock price is $0.0004 today.

Is MediXall Group, Inc. stock public?

Yes, MediXall Group, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Check Those
Similar Market Cap